Obliterative bronchiolitis (OB) is a serious long-term complication after bone marrow transplantation (BMT), and develops in about 10% of patients. 1 There is no doubt that OB is related to an alloimmune reaction because it is rare in other situations. However, there are likely to be other contributing factors because the disease has 'tropism' to some patients and the small airways. There are reports suggesting the possible contribution of viral infection in the development of OB, 2 but this has not been proven yet. Human herpesvirus (HHV)-6 infects various types of cells, and can reactivate in immunosuppressed individuals, including after BMT. 3 Its presence has been observed in the lungs of BMT patients with interstitial pneumonia. 4 However, the relationship between OB and HHV-6 has not been studied. Here, we report a patient with OB after BMT in whom we show the localization of HHV-6 in the small airways by indirect in situ polymerase chain reaction (PCR) for the first time.
A 29-year-old man was admitted to the hospital in January 2001 because of worsening dyspnea since November 2000 (Figure 1 ). In November 1999, he received BMT from one locus (HLA-DR) mismatched unrelated donor for acute lymphoid leukemia. Prednisolone (PSL) and cyclosporine (CsA) were administered for the prophylaxis of graft-versus-host disease (GVHD). Conditioning consisted of cyclophosphamide 60 mg/kg for 2 days and a total body irradiation of 12 Gy. He developed grade I acute GVHD. In May 2000, CsA was stopped. In June 2000, he developed extensive chronic GVHD in the oral cavity, eyes and the liver and 1 mg/kg of PSL was started. In August 2000, ganciclovir (GCV) was administered for 2 weeks because cytomegalovirus (CMV) antigenemia was positive in his blood. The chronic GVHD resolved and PSL was tapered to 15 and 20 mg/day in turn.
On admission, physical and radiological examinations of the chest revealed no abnormalities. However, spirometry showed severe obstruction (48.3% of his maximum value of forced expiratory volume at 1 s (FEV 1 )). We performed thoracoscopic lung biopsy. His lung showed severe fibrosis beneath the bronchiolar epithelium and some epithelial cell detachment in the bronchioles (Figure 2a ). These findings indicated that he had developed OB. In the airway lumen, CD68 positive foamy cells were observed (Figure 2a, b) , suggesting infection with herpesviridae. We therefore performed PCR for HHV-6, -7, Epstein-Barr virus and CMV on the lung specimen, and positive signals were detected only by primers for HHV-6 (data not shown). We further performed in situ PCR and found that some of the foamy cells and bronchiolar epithelium were positive for HHV-6 (Figure 2c ). The lung was negative for hepatitis B virus (HBV) used as a negative control (Figure 2d) .
The doses of PSL were increased and CsA was restarted after the diagnosis, but the patient complained of worsening dyspnea and his vital capacity (VC), forced vital capacity (FVC), and FEV 1 decreased by 330, 440, and 100 ml, respectively, in 2 weeks. Therefore, GCV, which is effective against HHV-6, 5 was added after this short followup with PSL and CsA. Thereafter, his symptoms and FEV 1 recovered and have been stable for more than 2 years ( Figure 1 ). However, we had to interrupt GCV administration twice due to its adverse effects. Meanwhile, the doses of immunosuppressants were gradually reduced as usual for BMT patients. With every decrease of immunosuppresants during the GCV-free period, FEV 1 and FVC decreased, and restarting GCV and increasing the doses of immunosuppressants improved the condition.
In our patient, the HHV-6 genome was observed at the site of inflammation in the lung, and combined antiviral medication seemed to be effective in preventing further deterioration of his symptoms and pulmonary function. These suggest that HHV-6 was involved in the pathogenesis of OB. The contribution of viral infection to the development of OB has been studied. It has been reported that the status of CMV antibody in the donor and recipient before transplantation is related to the development of OB. 6 Further, in a rat model of tracheal allograft, rat CMV infection augmented the tracheal lumen narrowing, and the combination of GCV and immunosuppressive therapy suppressed the lumen obstruction. 7 In our patient, the direct contribution of CMV may be excluded, because the lung specimen was negative on PCR with CMV primers, and CMV antigenemia was negative from the beginning of the follow-up (January 2001). The possible involvement of infections with other viruses, such as respiratory syncytial virus, parainfluenza virus, and influenza virus, has been reported, 1 but their contributions have not been thoroughly studied.
We observed the accumulation of macrophages in the small airways in our patient. Macrophage/dendritic cells have important roles in transplant rejection not only by presenting antigens to T cells but also by releasing proinflammatory cytokines. 8 An increase in the number of macrophages/dendritic cells in OB patients has been reported. 9 It is already known that HHV-6 infects monocytes/macrophages in vitro and in vivo, and HHV-6 infection of those cells induces functional alterations and the expression of chemokine receptors of virus origin, such as U12 and U51, which react to human chemokines. 
